PMC:7035340 / 7261-7503 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"235","span":{"begin":122,"end":130},"obj":"Species"},{"id":"236","span":{"begin":218,"end":226},"obj":"Species"},{"id":"237","span":{"begin":232,"end":241},"obj":"Species"},{"id":"238","span":{"begin":118,"end":121},"obj":"Disease"},{"id":"239","span":{"begin":203,"end":217},"obj":"Disease"}],"attributes":[{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"Tax:9606"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"Tax:9606"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Tax:2697049"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:C000657245"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, our clinical experience and available descriptive data from the therapeutic process of the first 15 critical NCP patients are prone to support corticosteroids treatment for specific subgroup of critically ill patients with 2019-nCoV."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42","span":{"begin":152,"end":167},"obj":"Chemical"}],"attributes":[{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"However, our clinical experience and available descriptive data from the therapeutic process of the first 15 critical NCP patients are prone to support corticosteroids treatment for specific subgroup of critically ill patients with 2019-nCoV."}

{"project":"LitCovid-sentences","denotations":[{"id":"T35","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, our clinical experience and available descriptive data from the therapeutic process of the first 15 critical NCP patients are prone to support corticosteroids treatment for specific subgroup of critically ill patients with 2019-nCoV."}